{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:46Z","timestamp":1707524446656},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,3]]},"DOI":"10.7759\/cureus.20892","type":"journal-article","created":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T14:21:48Z","timestamp":1641219708000},"source":"Crossref","is-referenced-by-count":1,"title":["A Unique Interaction of Methotrexate and Nitrofurantoin Resulting in Irreversible Pulmonary Fibrosis"],"prefix":"10.7759","author":[{"given":"Smriti","family":"Kochhar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veera Jayasree Latha","family":"Bommu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Kocur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viraj","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pramil","family":"Cheriyath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/0049-0172(87)90020-5","article-title":"Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy","volume":"16","author":"Roschmann RA","year":"1987","unstructured":"Roschmann RA, Rothenberg RJ. Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy. Semin Arthritis Rheum. 1987, 16:174-85. 10.1016\/0049-0172(87)90020-5","journal-title":"Semin Arthritis Rheum"},{"key":"ref2","article-title":"Nitrofurantoin","author":"Squadrito FJ","year":"2021","unstructured":"Squadrito FJ, del Portal D. Nitrofurantoin. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14744\/nci.2015.97759","article-title":"Pulmonary fibrosis developed secondary to methotrexate use in a patient with psoriasis vulgaris","volume":"2","author":"Karadag AS","year":"2015","unstructured":"Karadag AS, Kanbay A, Ozlu E, Uzuncakmak TK, Gedik C, Akdeniz N. Pulmonary fibrosis developed secondary to methotrexate use in a patient with psoriasis vulgaris. North Clin Istanb. 2015, 2:159-61. 10.14744\/nci.2015.97759","journal-title":"North Clin Istanb"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-957337","article-title":"Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis","volume":"27","author":"Swigris JJ","year":"2006","unstructured":"Swigris JJ, Brown KK. Acute interstitial pneumonia and acute exacerbations of idiopathic pulmonary fibrosis. Semin Respir Crit Care Med. 2006, 27:659-67. 10.1055\/s-2006-957337","journal-title":"Semin Respir Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkv147","article-title":"Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials","volume":"70","author":"Huttner A","year":"2015","unstructured":"Huttner A, Verhaegh EM, Harbarth S, Muller AE, Theuretzbacher U, Mouton JW. Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials. J Antimicrob Chemother. 2015, 70:2456-64. 10.1093\/jac\/dkv147","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.suppl_a.23","article-title":"Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens","volume":"33","author":"McOsker CC","year":"1994","unstructured":"McOsker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother. 1994, 33:23-30. 10.1093\/jac\/33.suppl_a.23","journal-title":"J Antimicrob Chemother"},{"key":"ref7","article-title":"Nitrofurantoin pulmonary toxicity","volume":"13","author":"Hainer BL","year":"1981","unstructured":"Hainer BL, White AA. Nitrofurantoin pulmonary toxicity. J Fam Pract. 1981, 13:817-23.","journal-title":"J Fam Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr395","article-title":"Antibiotic use in long-term care facilities","volume":"66","author":"Daneman N","year":"2011","unstructured":"Daneman N, Gruneir A, Newman A, et al.. Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011, 66:2856-63. 10.1093\/jac\/dkr395","journal-title":"J Antimicrob Chemother"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2174\/1874306401206010063","article-title":"Drug induced interstitial lung disease","volume":"6","author":"Schwaiblmair M","year":"2012","unstructured":"Schwaiblmair M, Behr W, Haeckel T, M\u00e4rkl B, Foerg W, Berghaus T. Drug induced interstitial lung disease. Open Respir Med J. 2012, 6:63-74. 10.2174\/1874306401206010063","journal-title":"Open Respir Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/313858","article-title":"Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis","volume":"2013","author":"Patan\u00e8 M","year":"2013","unstructured":"Patan\u00e8 M, Ciriaco M, Chimirri S, et al.. Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis. Adv Pharmacol Sci. 2013, 2013:313858. 10.1155\/2013\/313858","journal-title":"Adv Pharmacol Sci"},{"key":"ref11","article-title":"Rheumatologists' recommended patient information when prescribing methotrexate for rheumatoid arthritis","volume":"28","author":"Thompson AE","year":"2010","unstructured":"Thompson AE, Bashook PG. Rheumatologists' recommended patient information when prescribing methotrexate for rheumatoid arthritis. Clin Exp Rheumatol. 2010, 28:539-45.","journal-title":"Clin Exp Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1078155218813691","article-title":"Altered methotrexate clearance in the treatment of CNS lymphoma with concurrent use of nitrofurantoin for a urinary tract infection","volume":"25","author":"Gowarty JL","year":"2019","unstructured":"Gowarty JL, Patel IJ, Herrington JD. Altered methotrexate clearance in the treatment of CNS lymphoma with concurrent use of nitrofurantoin for a urinary tract infection. J Oncol Pharm Pract. 2019, 25:1794-7. 10.1177\/1078155218813691","journal-title":"J Oncol Pharm Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.80","article-title":"Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts","volume":"129","author":"Ramser B","year":"2009","unstructured":"Ramser B, Kokot A, Metze D, Weiss N, Luger TA, B\u00f6hm M. Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts. J Invest Dermatol. 2009, 129:2419-26. 10.1038\/jid.2009.80","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2020.104025","article-title":"Evolution and treatment of idiopathic pulmonary fibrosis","volume":"49","author":"Torrisi SE","year":"2020","unstructured":"Torrisi SE, Kahn N, Vancheri C, Kreuter M. Evolution and treatment of idiopathic pulmonary fibrosis. Presse Med. 2020, 49:104025. 10.1016\/j.lpm.2020.104025","journal-title":"Presse Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1378\/chest.109.4.933","article-title":"Pulmonary function in patients receiving long-term low-dose methotrexate","volume":"109","author":"Cottin V","year":"1996","unstructured":"Cottin V, T\u00e9bib J, Massonnet B, Souquet PJ, Bernard JP. Pulmonary function in patients receiving long-term low-dose methotrexate. Chest. 1996, 109:933-8. 10.1378\/chest.109.4.933","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/81527-a-unique-interaction-of-methotrexate-and-nitrofurantoin-resulting-in-irreversible-pulmonary-fibrosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:35:29Z","timestamp":1707507329000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/81527-a-unique-interaction-of-methotrexate-and-nitrofurantoin-resulting-in-irreversible-pulmonary-fibrosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.20892","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,3]]}}}